VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 2051 · 109th Congress

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005 - Amends title II (Old Age, Survivors and Disability Insurance)(OASDI) of the Social Security Act (SSA) to eliminate the time limitations for coverage of immunosuppressive drugs for individuals who receive a kidney transplant or other organ transplant.

What it does: CRS summary · Introduced in House · May 3, 2005

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005 - Amends title II (Old Age, Survivors and Disability Insurance)(OASDI) of the Social Security Act (SSA) to eliminate the time limitations for coverage of immunosuppressive drugs for individuals who receive a kidney transplant or other organ transplant.

Amends title XVIII (Medicare ) of SSA to apply special rules to individuals receiving additional coverage for immunosuppressive drugs, including: (1) that such individual is deemed to be enrolled under Medicare part B for purposes of receiving such coverage; (2) that such individual is responsible for the full amount of the applicable premiums; and (3) that deductible and coinsurance amounts apply. Requires the Secretary of Health and Human Services to establish procedures for implementing such coverage.

Extends Medicare secondary payer requirements for end stage renal disease beneficiaries.

Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to require a group health plan or issuer to provide coverage of immunosuppressive drugs that is at least as comprehensive as coverage provided on the date of enactment of this Act.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2005

Latest action (May 20, 2005): Referred to the Subcommittee on Employer-Employee Relations.

Policy area: Health · Origin: House · Introduced: May 3, 2005

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.